Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC).
暂无分享,去创建一个
M. Fakih | S. Rahmanuddin | A. Schrock | J. Chao | S. Ali | C. Lau | D. Lim | I. Amanam | D. Chevalier | C. Wang | E. Harris | J. Saluja